Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome
- PMID: 27725146
- DOI: 10.1053/j.gastro.2016.09.049
Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome
Abstract
Background & aims: We have limited knowledge about the association between the composition of the intestinal microbiota and clinical features of irritable bowel syndrome (IBS). We collected information on the fecal and mucosa-associated microbiota of patients with IBS and evaluated whether these were associated with symptoms.
Methods: We collected fecal and mucosal samples from adult patients who met the Rome III criteria for IBS at a secondary/tertiary care outpatient clinics in Sweden, as well as from healthy subjects. The exploratory set comprised 149 subjects (110 with IBS and 39 healthy subjects); 232 fecal samples and 59 mucosal biopsy samples were collected and analyzed by 16S ribosomal RNA targeted pyrosequencing. The validation set comprised 46 subjects (29 with IBS and 17 healthy subjects); 46 fecal samples, but no mucosal samples, were collected and analyzed. For each subject, we measured exhaled H2 and CH4, oro-anal transit time, and the severity of psychological and gastrointestinal symptoms. Fecal methanogens were measured by quantitative polymerase chain reaction. Numerical ecology analyses and a machine learning procedure were used to analyze the data.
Results: Fecal microbiota showed covariation with mucosal adherent microbiota. By using classic approaches, we found no differences in fecal microbiota abundance or composition between patients with IBS vs healthy patients. A machine learning procedure, a computational statistical technique, allowed us to reduce the 16S ribosomal RNA data complexity into a microbial signature for severe IBS, consisting of 90 bacterial operational taxonomic units. We confirmed the robustness of the intestinal microbial signature for severe IBS in the validation set. The signature was able to discriminate between patients with severe symptoms, patients with mild/moderate symptoms, and healthy subjects. By using this intestinal microbiota signature, we found IBS symptom severity to be associated negatively with microbial richness, exhaled CH4, presence of methanogens, and enterotypes enriched with Clostridiales or Prevotella species. This microbiota signature could not be explained by differences in diet or use of medications.
Conclusions: In analyzing fecal and mucosal microbiota from patients with IBS and healthy individuals, we identified an intestinal microbiota profile that is associated with the severity of IBS symptoms.
Trial registration number: NCT01252550.
Keywords: Bacteria; Functional Bowel Disorder; Microbiome.
Copyright © 2017 AGA Institute. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.Dig Dis Sci. 2018 Jul;63(7):1890-1899. doi: 10.1007/s10620-018-5086-4. Epub 2018 May 17. Dig Dis Sci. 2018. PMID: 29777439
-
Fecal microbiota transplantation for managing irritable bowel syndrome.Expert Rev Gastroenterol Hepatol. 2018 May;12(5):439-445. doi: 10.1080/17474124.2018.1447380. Epub 2018 Mar 8. Expert Rev Gastroenterol Hepatol. 2018. PMID: 29493330 Review.
-
Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: A systematic review and meta-analysis.Dig Liver Dis. 2017 Apr;49(4):331-337. doi: 10.1016/j.dld.2017.01.142. Epub 2017 Jan 21. Dig Liver Dis. 2017. PMID: 28179092 Review.
-
Lactulose Challenge Determines Visceral Sensitivity and Severity of Symptoms in Patients With Irritable Bowel Syndrome.Clin Gastroenterol Hepatol. 2016 Feb;14(2):226-33.e1-3. doi: 10.1016/j.cgh.2015.09.039. Epub 2015 Oct 20. Clin Gastroenterol Hepatol. 2016. PMID: 26492847
-
Relationship Between Microbiota of the Colonic Mucosa vs Feces and Symptoms, Colonic Transit, and Methane Production in Female Patients With Chronic Constipation.Gastroenterology. 2016 Feb;150(2):367-79.e1. doi: 10.1053/j.gastro.2015.10.005. Epub 2015 Oct 13. Gastroenterology. 2016. PMID: 26460205 Free PMC article.
Cited by
-
Effectiveness of a Balanced Nine-Strain Synbiotic in Primary-Care Irritable Bowel Syndrome Patients-A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial.Nutrients. 2024 May 16;16(10):1503. doi: 10.3390/nu16101503. Nutrients. 2024. PMID: 38794741 Free PMC article. Clinical Trial.
-
The Emerging Role of Human Gut Bacteria Extracellular Vesicles in Mental Disorders and Developing New Pharmaceuticals.Curr Issues Mol Biol. 2024 May 15;46(5):4751-4767. doi: 10.3390/cimb46050286. Curr Issues Mol Biol. 2024. PMID: 38785554 Free PMC article. Review.
-
Effectiveness of Probiotic Use in Alleviating Symptoms of Irritable Bowel Syndrome: A Systematic Review.Cureus. 2024 Apr 15;16(4):e58306. doi: 10.7759/cureus.58306. eCollection 2024 Apr. Cureus. 2024. PMID: 38752062 Free PMC article. Review.
-
Regulation and analysis of Simiao Yong'an Decoction fermentation by Bacillus subtilis on the diversity of intestinal microbiota in Sprague-Dawley rats.Vet World. 2024 Mar;17(3):712-719. doi: 10.14202/vetworld.2024.712-719. Epub 2024 Mar 25. Vet World. 2024. PMID: 38680148 Free PMC article.
-
A Systematic Review: Fecal Bacterial Profile in Patients with Irritable Bowel Syndrome Analyzed with the GA-Map Dysbiosis Test Based on the 16S rRNA Gene of Bacterial Species or Groups.Clin Exp Gastroenterol. 2024 Apr 17;17:109-120. doi: 10.2147/CEG.S451675. eCollection 2024. Clin Exp Gastroenterol. 2024. PMID: 38646157 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous